ADC Therapeutics S.A. (ADCT)
NYSE: ADCT
· Real-Time Price · USD
3.13
-0.06 (-1.88%)
At close: Aug 15, 2025, 3:59 PM
3.13
-0.04%
After-hours: Aug 15, 2025, 06:42 PM EDT
ADC Therapeutics S.A. Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 70.19M | 70.84M | 70.72M | 66.75M | 68.62M | 69.56M | 122.57M | 184.39M | 182.4M | 209.91M | 157.12M | 93.95M | 80.42M | 33.92M | 68.81M | 55.66M | 51.9M |
Cost of Revenue | 6.34M | 7.63M | 7.47M | 6.99M | 6.25M | 3.49M | 2.76M | 3.69M | 4.64M | 4.58M | 4.86M | 4.07M | 1.92M | 1.97M | 27.15M | 58.8M | 84.63M |
Gross Profit | 63.85M | 63.21M | 63.24M | 59.76M | 62.37M | 66.07M | 119.8M | 180.7M | 177.76M | 205.33M | 152.26M | 89.88M | 78.49M | 31.95M | 41.66M | -3.14M | -32.73M |
Operating Income | -125.5M | -130.65M | -138.2M | -140.04M | -150.78M | -168.74M | -139.5M | -95.23M | -124.85M | -113.65M | -165.69M | -230.35M | -231.42M | -261.72M | -276.94M | -271.58M | -246.04M |
Interest Income | 11.38M | 12.27M | 12.93M | 12.63M | 11.75M | 11.11M | 9.44M | 6.58M | 4.22M | 20.22M | 18.62M | 18.36M | 18.36M | 66K | 146K | 293K | 473K |
Pretax Income | -149.14M | -156.7M | -165.53M | -169.8M | -187.5M | -201.18M | -181.5M | -184.92M | -196.52M | -154.66M | -190.82M | -210.91M | -217.92M | -251.5M | -250.96M | -199.88M | -254.01M |
Net Income | -149.84M | -157.85M | -212.15M | -215.99M | -226.56M | -239.38M | -178.51M | -181.31M | -198.56M | -155.8M | -166.02M | -186.97M | -195.16M | -230.03M | -251.57M | -200.35M | -254.34M |
Selling & General & Admin | 61.89M | 85.91M | 90.26M | 92.67M | 98.19M | 105.27M | 111.36M | 124.73M | 134.17M | 141.06M | 146.27M | 143.44M | 142.13M | 136.24M | 129.16M | 115.8M | 100.21M |
Research & Development | 112.83M | 109.63M | 112.86M | 108.8M | 116.45M | 130.19M | 148.6M | 161.83M | 178.43M | 187.9M | 181.66M | 176.79M | 167.78M | 158M | 164.06M | 159.41M | 145.83M |
Other Expenses | 2.23M | 2.49M | 2.49M | 2.49M | 559K | 296K | 296K | 296K | 114K | 122K | 122K | 122K | 8K | n/a | 143K | 34.16M | -46.55M |
Operating Expenses | 173.88M | 193.86M | 201.44M | 199.79M | 213.15M | 234.81M | 259.31M | 285.91M | 312.6M | 328.96M | 327.93M | 320.23M | 309.91M | 294.24M | 293.22M | 275.21M | 246.04M |
Interest Expense | 49.95M | 50.21M | 45.97M | 45.79M | 43.42M | 41.34M | 43.47M | 41.89M | 40.38M | 39.18M | 38.89M | 31.8M | 25.56M | 18.34M | 10.87M | 8.54M | 6.88M |
Selling & Marketing Expenses | 5.08M | 21.44M | 29.64M | 32.62M | 36.1M | 45.64M | 47.89M | 48.09M | 57.42M | 60.44M | 62.87M | 71.68M | 69.24M | 64.78M | 55.53M | 44.6M | 33.38M |
Cost & Expenses | 180.22M | 201.49M | 208.91M | 206.78M | 219.4M | 238.3M | 262.07M | 289.61M | 317.24M | 333.54M | 332.79M | 324.29M | 311.83M | 295.64M | 293.85M | 275.34M | 246.04M |
Income Tax Expense | -482K | -401K | 43.09M | 42.91M | 36.39M | 36.21M | -2.99M | -3.62M | 2.05M | 1.14M | -24.8M | -23.94M | -22.76M | -21.48M | 618K | 470K | 334K |
Shares Outstanding (Basic) | 107.2M | 105.4M | 104.82M | 95.69M | 82.55M | 82.29M | 82.26M | 81.47M | 80.81M | 80.64M | 78.37M | 76.91M | 76.82M | 76.4M | 76.74M | 76.73M | 76.72M |
Shares Outstanding (Diluted) | 107.2M | 105.4M | 104.82M | 95.69M | 82.55M | 82.29M | 82.26M | 81.47M | 80.81M | 80.64M | 78.37M | 76.91M | 76.82M | 76.4M | 76.74M | 76.73M | 76.72M |
EPS (Basic) | -1.45 | -1.65 | -2.39 | -2.55 | -2.75 | -2.93 | -2.2 | -2.27 | -2.53 | -2.01 | -2.16 | -2.44 | -2.55 | -3 | -3.28 | -2.64 | -3.7 |
EPS (Diluted) | -1.45 | -1.65 | -2.39 | -2.55 | -2.75 | -2.93 | -2.2 | -2.27 | -2.53 | -2.01 | -2.16 | -2.44 | -2.55 | -3 | -3.28 | -2.64 | -3.7 |
EBITDA | -99.25M | -103.44M | -111.84M | -115.14M | -129.74M | -144.43M | -125.77M | -130.16M | -147.17M | -105.33M | -140.34M | -167.23M | -182.24M | -225.03M | -234.66M | -188.29M | -244.71M |
EBIT | -72.98M | -106.49M | -114.33M | -117.61M | -136.6M | -151.14M | -136.82M | -143M | -157.17M | -115.23M | -149.43M | -174.39M | -187.65M | -230.43M | -237.35M | -190.81M | -246.6M |
Depreciation & Amortization | 2.43M | 3.28M | 3.49M | 3.48M | 3.42M | 3.27M | 3.06M | 2.84M | 2.65M | 2.55M | 2.51M | 2.6M | 2.65M | 2.63M | 2.69M | 2.52M | 2.32M |